Philippe Menu, Chief Product Officer and Chief Medical Officer at SOPHiA GENETICS, shared a post on LinkedIn:
“Super nice to see the publication this week in NPJ Artificial Intelligence of our latest perspectives on the ongoing AI multimodal revolution in oncology, alongside our wonderful partners at AstraZeneca, Memorial Sloan Kettering Cancer Center and NVIDIA.
The paper is a collaborative review of the current status and direction of travel of applying AI to multimodal data stacks across the oncology care continuum.
Excited to specifically see our joint work on the TRIDENT and ABACO initiatives with AstraZeneca and Memorial Sloan Kettering Cancer Center called out!
Warmly recommend the read!
Agree or disagree with the perspectives contained in the paper? Please comment.”
Title: The AI revolution: how multimodal intelligence will reshape the oncology ecosystem
Authors: David Dellamonica, David Ruau, Ben Griffiths, Greg Rossi, Bob T. Li, Pedram Razavi, Thomas Di Maio, Tristan Gonzalez, Amanda Remorino, Jorge S. Reis-Filho, Philippe Menu, Thorsten Gutjahr, Adrien Moucquot, Tom Diethe, Hassan Naqvi, Ross Muken, Pablo Azcue
Read the Full Article.
More posts on OncoDaily.